Sabra Health Care Reit, Inc. (SBRA) Stock Price & Analysis
Sabra Health Care Reit, Inc. (SBRA) rose 4.07% to USD 18.9 as of June 10, 2026 at 00:51 UTC, according to Nexqual real-time market data.
SBRA last closed at USD 18.16; the session ranged USD 18.17–18.96 on volume of 2,903,149 shares. Market capitalization is $4.77B, with a 52-week range of USD 17.17–21.28 (NMS). Source: Nexqual, June 10, 2026 at 00:51 UTC.
Key Statistics (as of June 10, 2026 at 00:51 UTC)
| Price | USD 18.9 |
|---|---|
| Change | ▲ 4.07% (up) |
| Previous Close | USD 18.16 |
| Open | USD 18.17 |
| Day Range | USD 18.17 – 18.96 |
| 52-Week Range | USD 17.17 – 21.28 |
| Volume | 2,903,149 shares |
| Market Cap | $4.77B |
| Exchange | NMS |
Technical Analysis (SBRA)
Nexqual's technical model rates SBRA "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:51 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 43.43 (neutral) |
| vs SMA50 | Below (USD 20.11) |
| MACD | -0.58 (negative) |
Analyst Ratings (SBRA)
Wall Street analysts rate SBRA "Buy" based on 13 analysts, with a mean price target of USD 22.77 (range USD 20–25), per Nexqual as of June 10, 2026 at 00:51 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 13 |
| Mean Target | USD 22.77 |
| High Target | USD 25 |
| Low Target | USD 20 |
| Buy / Hold / Sell | 6 / 8 / 0 |
Earnings (SBRA)
| Next Earnings Date | 2026-04-29 |
|---|---|
| EPS Estimate | USD 0.17 |
| Revenue Estimate | $213.33M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.16 vs est 0.16 ▲ beat |
| 2025-12-31 | USD 0.16 vs est 0.16 ▼ miss |
| 2025-09-30 | USD 0.17 vs est 0.18 ▼ miss |
| 2025-06-30 | USD 0.25 vs est 0.17 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financials & Fundamentals (SBRA)
| Total Revenue | $815.66M |
|---|---|
| Revenue Growth (YoY) | +21.70% |
| Gross Margin | +63.74% |
| Operating Margin | +31.41% |
| Profit Margin | +19.15% |
| ROE | +5.68% |
| Debt / Equity | 95.86 |
| Current Ratio | 2.62 |
| Total Cash | $124.18M |
| Total Debt | $2.67B |
| Free Cash Flow | $197.84M |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financial Health Score (SBRA)
Nexqual rates Sabra Health Care Reit, Inc.'s overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:51 UTC.
| Growth | Solid — Revenue +10% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 64%, operating 31% |
| Balance Sheet | Mixed — $124M cash vs $2.67B debt |
| Cash Flow | Strong — FCF $198M, 26% margin |
| Efficiency | Mixed — ROE 6%, ROA 3.1% |
Ownership (SBRA)
| Insider Ownership | +1.40% |
|---|---|
| Institutional Ownership | +108.09% |
| Shares Outstanding | 252.19M |
| Float | 247.96M |
| Short % of Float | +16.03% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Leadership (SBRA)
Sabra Health Care Reit, Inc. is led by Richard K. Matros (age 71), Chairman, President & CEO, per Nexqual as of June 10, 2026 at 00:51 UTC.
| Chairman, President & CEO | Richard K. Matros (age 71) |
|---|---|
| Executive VP, CFO & Treasurer | Michael Lourenco Costa (age 46) |
| Executive Vice President of Strategic Initiatives | Peter W. Nyland |
| Executive Vice President of Finance | Lukas Michael Hartwich C.F.A. |
Major Backers & Investors (SBRA)
Notable institutional backers of Sabra Health Care Reit, Inc. include Principal Financial Group, Inc., JPMorgan, Principal Funds, Inc-Real Estate Securities Fund, according to Nexqual as of June 10, 2026 at 00:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Principal Financial Group, Inc. | 9.93% |
| JPMorgan | 3.25% |
| Principal Funds, Inc-Real Estate Securities Fund | 3.17% |
| Bank of America Corporation | 2.14% |
| Charles Schwab Investment Management, Inc. | 1.89% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 25.22% |
| BlackRock | 22.04% |
| State Street | 4.8% |
| Geode Capital | 2.95% |
| Nuveen | 2.65% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
From Sabra Health Care Reit, Inc.'s Latest SEC 10-K Filing (filed 2026-02-12)
Key Strengths & Strategy (as disclosed to the SEC)
- Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OHI | Omega Healthcare Investors, Inc | USD 45.67 | ▲ 2.7% |
| NHI | National Health Investors, Inc. | USD 71.44 | ▲ 1.43% |
| CTRE | CareTrust REIT, Inc. | USD 37.7 | ▼ 0.71% |
| DOC | Healthpeak Properties, Inc. | USD 20.5 | ▲ 3.59% |
| LTC | LTC Properties, Inc. | USD 36.61 | ▲ 1.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:51 UTC. This page is informational and not investment advice.